Rakovina Therapeutics Inc (RKV : TSX-V)
Common Stock
$0.18
CAD
+0.00 (%)
Last updated: 2026-10-26
Follow RKV
RKV
Rakovina Therapeutics Inc
WealthAwesomePerformance
1 Day
+8.82%
1 Week
-15.91%
1 Month
-26.00%
YTD
+85.00%
Key Statistics
Market Cap
$4.52M
52W High
$0.32
52W Low
$0.09
P/E Ratio
-
50 Day MA
$0.22
200 Day MA
$0.15
Beta
-0.24
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 10/26/2026 | $0.20 | $0.20 | $0.17 | $0.17 | $0.17 | 5,525 |
| 10/23/2026 | $0.18 | $0.18 | $0.18 | $0.18 | $0.18 | 500 |
| 10/22/2026 | $0.17 | $0.17 | $0.17 | $0.17 | $0.17 | 1,522 |
| 10/21/2026 | $0.20 | $0.20 | $0.16 | $0.16 | $0.16 | 38,102 |
| 10/20/2026 | $0.23 | $0.23 | $0.18 | $0.18 | $0.18 | 6,501 |
| 10/19/2026 | $0.20 | $0.23 | $0.20 | $0.23 | $0.23 | 3,060 |
| 10/16/2026 | $0.22 | $0.22 | $0.22 | $0.22 | $0.22 | 600 |
| 10/15/2026 | $0.23 | $0.23 | $0.22 | $0.22 | $0.22 | 1,567 |
| 10/14/2026 | $0.22 | $0.25 | $0.22 | $0.23 | $0.23 | 3,590 |
| 10/13/2026 | $0.19 | $0.24 | $0.19 | $0.22 | $0.22 | 18,943 |
Analyst Price Targets
Based on analyst covering RKV · as of Sep 17, 2026
Wall Street analysts forecast RKV stock price to rise 35.1% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.25
+35.1% Upside
Current Price
C$0.18
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on RKV's historical volatility
30-Day Vol
130.2%
Annualized
90-Day Vol
152.8%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$0.20
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.18 | C$0.11 – C$0.27 |
| 60 trading days | C$0.19 | C$0.10 – C$0.35 |
| 90 trading days | C$0.20 | C$0.09 – C$0.43 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Rakovina Therapeutics Inc
Rakovina Therapeutics Inc., a biopharmaceutical research company, engages in the research and development of cancer treatments that target DNA-damage response systems. It develops kt-2000 series, which are patented class of oral, small molecule PARP inhibitors with established in vitro and in vivo proof of concept; kt-3000 series drug candidates, which are bi-functional targeted small molecules designed to inhibit both PARP and histone deacetylase; and kt-4000 series, which are small molecules engineered to induce targeted DNA damage in tumor cells. The company is also involved in the development of kt-5000 series of brain-penetrant dual ATR"mTOR inhibitor drug candidates. It has a strategic collaboration with Variational AI Inc. to develop AI-generated ATR inhibitor compounds; and a non-binding Letter of Intent to form a joint venture to co-develop AI-discovered small-molecule oncology therapies. Additionally, Rakovina Therapeutics Inc. has a strategic collaboration with Celvion Therapeutics to identify novel precision medicine strategies. The company was formerly known as Vincero Capital Corp. Rakovina Therapeutics Inc. is headquartered in Vancouver, Canada.
Financials
- Revenue (TTM)
- $0
- EBITDA
- $-5.88M
- Profit Margin
- 0.00%
- ROE (TTM)
- -1352.29%
- EPS (Diluted)
- -0.28
- Book Value
- -0.09
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About RKV
Market movers
Recent TSX-V movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| GRI | Galore Resources Inc | $0.02 | +100.00% |
| PWRO | Power One Resources Corp. | $0.03 | +66.67% |
| PCQ | Petrolympic Ltd | $0.17 | +61.90% |
| JADE | Jade Leader Corp | $0.02 | +33.33% |
| NKW-H | Oceanic Wind Energy Inc. | $0.13 | +31.58% |
| YAY | THS Maple Holdings Ltd. | $0.13 | +30.00% |
| GSS | Gossan Resources Ltd | $0.04 | +28.57% |
| AKH-H | Alaska Hydro Corporation | $0.03 | +25.00% |
RKV.V news timeline
10 articles covering RKV.V, most recent first
LatestWhat's Going On With Rakovina Therapeutics Inc Stock Thursday?
September 2026
- Why Rakovina Therapeutics Inc stock surged yesterday
- Why Rakovina Therapeutics Inc stock plummeted yesterday
- Why Rakovina Therapeutics Inc stock plummeted yesterday
- What's Going On With Rakovina Therapeutics Inc Stock Wednesday?
- Why Rakovina Therapeutics Inc stock surged yesterday
- Why Rakovina Therapeutics Inc stock surged yesterday
- Why Rakovina Therapeutics Inc stock plummeted yesterday